Clinical trial
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
NCT00003650 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00003650 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma |
| Official title | Phase III Study of Combination Chemotherapy in Children With T Cell and Pre-B Cell Non-Hodgkin's Lymphoma |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, etoposide, mercaptopurine, methotrexate, methylprednisolone, mitoxantrone hydrochloride and 3 more |
| Enrollment | 179 |
| Start date | Feb 1, 1997 |
| Primary completion | Dec 1, 2008 |
| Completion | Nov 1, 2013 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 21, 2021 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: